The unlikely intersection of overlooked diseases, overlooked assets and overlooked founders is the place we've called home for the past 10 years. When enough droplets come together they form an ocean.
It's always great to read the PCOs. This one was particularly energizing for the rare disease drug and nutraceutical communities. Let me know how I can help! Well done, Perlara Team!
It's always great to read the PCOs. This one was particularly energizing for the rare disease drug and nutraceutical communities. Let me know how I can help! Well done, Perlara Team!
Very impressive. Best wishes for accelerated success!!
Super interesting and inspiring perspective Ethan, thank you for sharing
Would you be able to comment on the regulatory process to be able to move from preclinical models to the clinic?
Very impressive. Best wishes for accelerated success!!